| Singapore state investor Temasek Holdings on Tuesday launched a selldown of up to $25 million in Shanghai Pharmaceuticals, IFR reported, citing a term sheet of the transaction.
Temasek is offering 8 million shares of Shanghai Pharmaceuticals in an indicative range of HK$23.55 to HK$24.30 each, equivalent to a discount of up to 3 percent to Tuesday's close, added IFR, a Thomson Reuters publication. Goldman Sachs was hired as sole bookrunner of the selldown, the terms showed...............................................Full Article: Source
|